<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2018">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134896</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003209</org_study_id>
    <nct_id>NCT05134896</nct_id>
  </id_info>
  <brief_title>Visual Performance With Spatial Light Modulator</brief_title>
  <official_title>Visual Performance After Optically Correcting the Eye's Aberration With a Spatial Light Modulator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eye's aberrations have been known to degrade human visual performance and the visual&#xD;
      performance is significantly improved when correcting the aberrations in the central visual&#xD;
      field. However, how the aberration correction affects the peripheral visual performance is&#xD;
      not well understood. Moreover, how central and peripheral vision interacts remains unclear.&#xD;
&#xD;
      To conduct the study, we will use an adaptive optics vision simulator equipped with a&#xD;
      Shack-Hartmann wavefront sensor and a spatial light modulator (see details in procedures&#xD;
      section of the protocol). This system is capable of noninvasively controlling the eye's&#xD;
      optical quality and evaluating visual performance simultaneously over a wide area of visual&#xD;
      space. This study provides insights into the visual performance in the periphery visual&#xD;
      field, and interaction between central and peripheral visual fields.&#xD;
&#xD;
      The goal of this study is to evaluate the visual performance at central and peripheral visual&#xD;
      fields after correcting the ocular aberrations. An optical system equipped with a liquid&#xD;
      crystal spatial light modulator will be used to achieve this goal non-invasively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>up to 6 separate sessions (each session taking up to 2 hours)</time_frame>
    <description>Snellen &quot;Tumbling E&quot; method will be used to determine the smallest letter that a subject can see.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>up to 6 separate sessions (each session taking up to 2 hours)</time_frame>
    <description>Light and dark sinusoidal stripes (Gabor gratings) will used to determine the smallest contrast that a subject can see</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast perception</measure>
    <time_frame>up to 6 separate sessions (each session taking up to 2 hours)</time_frame>
    <description>Light and dark sinusoidal stripes (Gabor gratings) will used to determine differences in contrast perceived by the central and peripheral visual system</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Normal Healthy Eyes</condition>
  <arm_group>
    <arm_group_label>normal healthy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spatial light modulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spatial light modulator</intervention_name>
    <description>This device compensates for the eye's optical imperfections (aberrations) at the foveal and peripheral retina.</description>
    <arm_group_label>normal healthy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A person is eligible for inclusion in the study if he/she:&#xD;
&#xD;
          -  Is between the ages of 18 and 60.&#xD;
&#xD;
          -  Has normal corneas i.e. no corneal infections, no systemic pink eye, no clinically&#xD;
             significant dry eye, and no corneal dystrophies.&#xD;
&#xD;
          -  Has refractive errors less than +/- 10.0 Diopters in both eyes.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A person will be excluded from the study if he/she:&#xD;
&#xD;
          -  Adults between the ages of 18-60 who are unable to give informed consent&#xD;
&#xD;
          -  Individuals below 18 years old&#xD;
&#xD;
          -  Individuals above the age of 60&#xD;
&#xD;
          -  Pregnant women (self-reporting, hormonal changes may alter the refractive status of&#xD;
             the eye)&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Students for whom you have direct access to/influence on grades&#xD;
&#xD;
          -  People who do not understand or speak English&#xD;
&#xD;
          -  Has clinically significant dry eye.&#xD;
&#xD;
          -  Has clinically significant cataract.&#xD;
&#xD;
          -  Has spherical refractive error that exceeds the limits outlined above.&#xD;
&#xD;
          -  Is unable to hold his or her head steady for the duration of study measurements.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Geunyoung Yoon, PhD</last_name>
    <phone>7137437860</phone>
    <email>gyoon2@central.uh.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiakai Lyu, MS</last_name>
    <phone>6262953929</phone>
    <email>jlyu@central.uh.edu</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Houston</investigator_affiliation>
    <investigator_full_name>Geunyoung Yoon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

